- Postdoctoral: Emphasis on Mucosal Vaccine Development, the Biodesign Institute at Arizona State University, 2006 – 2008.
- PhD: Experimental Pathology Program, University of Texas Medical Branch, 2006.
- Wilkinson EM, Ilhan ZE, Herbst-Kralovetz MM. Microbiota–drug interactions: Impact on metabolism and efficacy of therapeutics. Maturitas. 2018. 112: Pages 53-63.
- Baker JM, Chase DM, Herbst-Kralovetz MM. Uterine Microbiota: Residents, Tourists, or Invaders? Front Immunol. 2018 Mar 2;9:208. doi: 10.3389/fimmu.2018.00208. eCollection 2018. Review. PMID: 29552006
- Łaniewski P, Gomez A, Hire G1, So M, Herbst-Kralovetz MM. Human Three-Dimensional Endometrial Epithelial Cell Model To Study Host Interactions with Vaginal Bacteria and Neisseria gonorrhoeae. Infect Immun. 2017
- Herbst-Kralovetz MM, Pyles RB, Ratner AJ, Sycuro LK, Mitchell C. New systems for studying intercellular interactions in bacterial vaginosis. J Infect Dis. 2016. PMID: 27449872
- Muhleisen A, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas. 2016 Sep. PMID: 27451320
For a complete listing of Dr. Herbst-Kralovetz's publications, search PubMed.
Host-microbe interactions and immunology; vaginal microbiome and sexually transmitted infections; cervical and endometrial cancer
Dr. Herbst-Kralovetz is broadly interested in understanding innate mucosal immune responses to resident bacteria, pathogens and microbial products at mucosal sites, including the female reproductive tract (FRT). Her lab is interested in studying the mucosal barrier function of the FRT and its role in host defense and maintaining mucosal homeostasis, which is widely relevant to infection, immunity, reproduction and even cancer. She has a long-standing interest in women’s health. Video: Research: Unlocking Mysteries in Women's Health